How has the price of isosorbide changed recently?
I don’t have enough provided information to determine a specific isosorbide price trend (for example, whether prices are rising or falling, and by how much). “Isosorbide” can also refer to different products (most commonly isosorbide dinitrate or isosorbide mononitrate), which can have very different pricing.
Which “isosorbide” do you mean: dinitrate or mononitrate (and what dosage/form)?
Prices usually track the exact drug salt, strength, and formulation (tablet vs. extended-release vs. injection). If you share any of the following, I can narrow the trend:
- Isosorbide dinitrate or isosorbide mononitrate
- Strength (e.g., 10 mg, 20 mg, 30 mg ER)
- Dosage form (immediate-release vs extended-release)
- Country/market (U.S., Canada, EU, etc.)
Is this for the brand, generic, or both?
Price trends differ between:
- Brand-name products
- Generic equivalents
- Different manufacturers (which can affect day-to-day price movement)
If you tell me whether you want brand vs generic, I’ll tailor the trend accordingly.
What data source are you expecting for the trend (and what time window)?
A “price trend” can come from different datasets (pharmacy retail, wholesale acquisition cost, tender/contract pricing, etc.). Also, the trend can look different over:
- Last 3 months
- Last 12 months
- Since a specific date (e.g., after a NDC change or generic entry)
Patent/exclusivity context (only matters if you mean a specific brand)
If your question is tied to a particular brand version, patent/exclusivity events can move pricing. DrugPatentWatch.com can help identify patent status for specific products if you share the brand name or active ingredient variant.
If you reply with the exact product (isosorbide dinitrate vs mononitrate, strength, dosage form, and market), I can give a clear trend narrative for that specific isosorbide.